home / stock / halb / halb news


HALB News and Press, Tykhe Corp From 08/30/21

Stock Information

Company Name: Tykhe Corp
Stock Symbol: HALB
Market: OTC
Website: halberdcorporation.com

Menu

HALB HALB Quote HALB Short HALB News HALB Articles HALB Message Board
Get HALB Alerts

News, Short Squeeze, Breakout and More Instantly...

HALB - Halberd Corporation Alzheimer's Disease Treatment Tests Yield Outstanding Results

JACKSON CENTER, PA / ACCESSWIRE / August 30, 2021 / Halberd Corp. (OTC PINK:HALB) provided an update on its Alzheimer's Disease eradication experimentation being conducted at Youngstown State University (YSU) and Arizona State University (ASU). Following standard scientific methodology, Ha...

HALB - Halberd Files Provisional Patent Application - Furthering Efforts on Alzheimer's Disease

JACKSON CENTER, PA / ACCESSWIRE / August 23, 2021 / Halberd Corp. (OTC PINK:HALB) announced filing a U. S. joint provisional patent application, "Treating Alzheimer's Disease Utilizing Extracorporeal Radio Frequency." The innovation is a result of Halberd's Sponsored Research conducted a...

HALB - Halberd Corp. VITA-SHIELD-MAX(TM) Available - Buy Now!

JACKSON CENTER, PA / ACCESSWIRE / August 18, 2021 / Halberd Corporation's (OTC PINK:HALB) Nutraceutical product, Vita-Shield-Max TM is now available on www.vitashieldmax.com . Vita-Shield-Max TM is a specially formulated Nutraceutical to help maintain a healthy immune system. William A...

HALB - Halberd's Disease Elimination Technology R&D at Youngstown State University (YSU) Draws Attention of CBS Affiliate WKBN

Jackson Center, Pennsylvania--(Newsfile Corp. - August 16, 2021) - Halberd Corporation's (OTC Pink: HALB) research at Youngstown State University (YSU) caught the attention of Youngstown, OH TV news station, WKBN, a CBS affiliate. The station's 5:00PM newscast on Friday, August 13, 2021, inclu...

HALB - Halberd Corporation Adds Blood-Borne Disease Treatment Capability with Addition of Noted Nephrologist

Jackson Center, Pennsylvania--(Newsfile Corp. - August 11, 2021) - Halberd Corporation (OTC Pink: HALB) today confirmed the addition of Dr. Ned Kronfol as a member of its Scientific Advisory Board. Dr. Kronfol is certified by the American Board of Internal Medicine and retired in 2019 as Adjun...

HALB - Halberd Corporation Adds Blood-Borne Disease Treatment Capability With Addition Of Noted Nephrologist

JACKSON CENTER, PA / ACCESSWIRE / August 11, 2021 / Halberd Corporation (OTC PINK:HALB) today confirmed the addition of Dr. Ned Kronfol as a member of its Scientific Advisory Board. Dr. Kronfol is certified by the American Board of Internal Medicine and retired in 2019 as Adjunct Clinical ...

HALB - Halberd Corporation's VITA-SHIELD-MAX(TM) Immunity Support Product Shipped

Jackson Center, Pennsylvania--(Newsfile Corp. - August 9, 2021) - Halberd Corporation (OTC Pink: HALB) reports Vita-Shield-Max TM , has been shipped! With COVID-19 cases back on the rise fueled by the Delta Variant, this "Immunity Support Nutraceutical Product" is arriving at the right tim...

HALB - Halberd Corporation Successfully Establishes Disease Eradication Proof-of-Concept - "Never Before Accomplished"

A Major Step Towards the Elimination of Multiple Infectious Diseases and Possible Treatment for Alzheimer's Disease/PTSD/CTE JACKSON CENTER, PA / ACCESSWIRE / July 28, 2021 / Halberd Corporation (OTC PINK:HALB) establishes "proof of concept" taking a major step towards the elimination...

HALB - Halberd Corp. Discovers a Proprietary Disease-Causing Antigen Removal Process

Method Does Not Require Antibody Conjugated Metallic Nanoparticles Jackson Center, Pennsylvania--(Newsfile Corp. - June 30, 2021) - Halberd Corporation (OTC Pink: HALB) announces a possible breakthrough method for the removal of the disease-causing antigen(s) that does not require the use of ...

HALB - Halberd Corporation's Proprietary Technology for Alzheimer's Disease Enters Stage 4 of 7 Stage Process

JACKSON CENTER, PA / ACCESSWIRE / June 21, 2021 / Halberd Corporation's (OTC PINK:HALB) proprietary technology enters stage 4 to address Alzheimer's Disease (and other potential diseases); eradicating the antibody-disease combination through radiofrequency waves or laser or other means. Cu...

Previous 10 Next 10